Useful Resources
Background/Epidemiology
Signs and Symptoms
Prognostication markers (lab findings, comorbidities, imaging findings)
-
-
N = 46,248
-
Most severe disease: HTN (OR 2.4), Respiratory disease (OR - 2.46), CVD (OR -3.42)
-
Not corrected for age, SES, smoking
-
-
Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study
-
On average 17 yrs older (age 68 vs 51)
-
HTN 48% vs 24%; T2DM/ CVD/ COPD more common too
-
Dyspnea 62% vs 31%
-
Lymphpenia 91% vs 47%
-
ALT, AST, Cr, CK, LDH, TnI, BNP, D-dimer higher in deceased
-
Guidelines for home management of patients
PPE Guidelines
-
-
Study suggesting surgical masks may not be enough for cough/sneezes
-
CoVID-specific therapies
-
A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19
-
COVID-19: consider cytokine storm syndromes and immunosuppression
-
Theory of HLH Response (immunosuppression beneficial?)
-
ICU Guidelines on Management of Respiratory Failure/ARDS
Safe Intubation/Safe Code Blues
ACE/ARBs
-
COVID-19 and Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers
-
Renin–Angiotensin–Aldosterone System Inhibitors in Patients with Covid-19
NSAIDs
Patients with CVD
Patients with Autoimmune Conditions
Patients with Diabetes
Pregnant Patients
Pediatric Patients
Resource Allocation Guidelines
Additional Resources
-
CoVID papers/ research
-
ICU specific educational resources
-
Community resources
-
Covid with Kids - "Home sequestration, home schooling, and staying sane"